Web NewDrugInformation.com

Plasma-lyte A In Plastic Container Drug - Plasma-lyte A In Plastic Container The trade name of the product as shown on the labeling. Dosage - INJECTABLE; INJECTION The product dosage form and route separated by a semi-colon. Active Ingredient(s) - Magnesium Chloride; Potassium Chloride; Sodium Acetate; Sodium Chloride; Sodium Gluconate Multiple ingredients are in alphabetical order. Strength - 30MG/100ML;37MG/100ML;368MG/100ML;526MG/100ML;502MG/100ML The potency of the active ingredient(s), Magnesium Chloride; Potassium Chloride; Sodium Acetate; Sodium Chloride; Sodium Gluconate. May repeat for multiple part products. Applicant - BAXTER HLTHCARE The firm name holding legal responsibility for Plasma-lyte A In Plastic Container. The firm name is condensed to a maximum twenty character unique string. New Drug Application (NDA) Number - 017378 The FDA assigned number to Plasma-lyte A In Plastic Container. Format is nnnnnn. Product Number - 002 The FDA assigned number to identify Plasma-lyte A In Plastic Container. Each strength is a separate product. May repeat for multiple part products. Format is nnn. Therapeutic Equivalence (TE) Code - AP The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products. Approval Date - Nov 22, 1982 The date Plasma-lyte A In Plastic Container was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982". Reference Listed Drug (RLD) - No The pioneer or innovator of Plasma-lyte A In Plastic Container. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No. Type - RX The group or category of approved drugs Plasma-lyte A In Plastic Container is in. Format is RX, OTC, DISCN. Applicant Full Name - Baxter Healthcare Corp The full name of the firm holding legal responsibility for the new application of Plasma-lyte A In Plastic Container. Plasma-lyte A In Plastic Container Sulfamylon 5% For Solution; Topical Plasma-lyte 56 In Plastic Container 32mg/100ml;128mg/100ml;234mg/100ml Injectable; Injection Isolyte S Ph 7.4 In Plastic Container 30mg/100ml;37mg/100ml;0.82mg/100ml;370mg/100ml;530mg/100ml;500mg/100ml;12mg/100ml Injectable; Injection Isolyte S Ph 7.4 In Plastic Container 30mg/100ml;37mg/100ml;0.82mg/100ml;370mg/100ml;530mg/100ml;500mg/100ml;12mg/100ml Injectable; Injection Isolyte S In Plastic Container 30mg/100ml;37mg/100ml;370mg/100ml;530mg/100ml;500mg/100ml Injectable; Injection Isolyte S In Plastic Container 30mg/100ml;37mg/100ml;370mg/100ml;530mg/100ml;500mg/100ml Injectable; Injection Normosol-r In Plastic Container 30mg/100ml;37mg/100ml;222mg/100ml;526mg/100ml;502mg/100ml Injectable; Injection Plasma-lyte 148 In Water In Plastic Container 30mg/100ml;37mg/100ml;368mg/100ml;526mg/100ml;502mg/100ml Injectable; Injection Plasma-lyte A In Plastic Container 30mg/100ml;37mg/100ml;368mg/100ml;526mg/100ml;502mg/100ml Injectable; Injection Sulfamylon Eq 85mg Base/gm Cream; Topical NewDrugInformation